Clinical Trials Browser

Phase 1 × OTHER × siltuximab × Clear all

NCT06447376 2025-05-11

Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

Phase 1 Recruiting

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin

NCT05665725 2025-01-31

Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma

Phase 1 Completed

Lymphoma, Non-Hodgkin

NCT05697510 2023-04-06

SILTUXILAM

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute